Iradimed Co (IRMD) — Cash Flow-to-Debt Ratio
Iradimed Co (IRMD) has a Cash Flow-to-Debt Ratio of 0.45x as of June 2026, meaning its operating cash flow of $5.94 Million could theoretically repay 0% of its total liabilities ($13.23 Million) in one year. See Iradimed Co financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Iradimed Co Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Iradimed Co across 14 annual periods. For the full cash flow conversion analysis, see Iradimed Co operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Iradimed Co (2012–2025)
Year-by-year debt coverage analysis for Iradimed Co. Check earnings quality score of Iradimed Co to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.76x | $24.95 Million | $14.16 Million | ▼ -20.9% |
| 2024 | 2.23x | $25.62 Million | $11.51 Million | ▲ +242.9% |
| 2023 | 0.65x | $13.47 Million | $20.74 Million | ▼ -23.4% |
| 2022 | 0.85x | $10.04 Million | $11.84 Million | ▼ -19.3% |
| 2021 | 1.05x | $11.26 Million | $10.71 Million | ▲ +75.0% |
| 2020 | 0.60x | $5.82 Million | $9.68 Million | ▼ -34.2% |
| 2019 | 0.91x | $10.23 Million | $11.20 Million | ▼ -19.6% |
| 2018 | 1.14x | $7.38 Million | $6.50 Million | ▲ +102.1% |
| 2017 | 0.56x | $3.42 Million | $6.08 Million | ▼ -68.3% |
| 2016 | 1.77x | $9.41 Million | $5.31 Million | ▼ -23.3% |
| 2015 | 2.31x | $7.65 Million | $3.31 Million | ▲ +116.1% |
| 2014 | 1.07x | $2.59 Million | $2.42 Million | ▲ +13.4% |
| 2013 | 0.94x | $1.47 Million | $1.56 Million | ▲ +45.8% |
| 2012 | 0.65x | $1.51 Million | $2.33 Million | — |